# Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy

**Authors:** Hongjie Huo, Yu Feng, Qiong Tang

PMC · DOI: 10.1007/s00280-024-04646-8 · Cancer Chemotherapy and Pharmacology · 2024-03-26

## Full-text entities

- **Genes:** F2RL1 (F2R like trypsin receptor 1) [NCBI Gene 2150] {aka GPR11, PAR2}
- **Diseases:** lung cancer (MESH:D008175)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11420334/full.md

---
Source: https://tomesphere.com/paper/PMC11420334